# Pulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166

> **NCT01201928** · — · TERMINATED · sponsor: **Mannkind Corporation** · enrollment: 3 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus
- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Comparator administered in parent trial
- **DRUG:** Technosphere Insulin Inhalation Powder

## Key facts

- **NCT ID:** NCT01201928
- **Lead sponsor:** Mannkind Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2010-10
- **Primary completion:** 2011-03
- **Final completion:** 2012-03
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Parent trials were either not initiated or terminated
- **Last updated:** 2012-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01201928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01201928, "Pulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01201928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*